Bydureon (by-DUR-ee-on), the new long-acting form of Byetta (exenatide) for type 2 diabetes

You'll see Bydureon (by-DUR-ee-on), the new long-acting form of Byetta (exenatide) for type 2 diabetes.

Bydureon is injected just once a WEEK...compared to twice a day for Byetta or once a day for Victoza (liraglutide).

It sometimes makes sense to add these glucagon-like peptide-1 (GLP-1) agonists to oral meds to improve glycemic control and help patients lose weight.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote